Analysts have been eager to weigh in on the Healthcare sector with new ratings on Qiagen (QGEN) and Sanofi (SNYNF).
Qiagen (QGEN)
In a report released yesterday, Sven Olaf Kuerten from DZ BANK AG upgraded Qiagen to Hold. The company’s shares closed last Thursday at $49.29.
Kuerten has an average return of 4.8% when recommending Qiagen.
According to TipRanks.com, Kuerten is ranked #6887 out of 7423 analysts.
Qiagen has an analyst consensus of Hold, with a price target consensus of $56.99.
See today’s analyst top recommended stocks >>
Sanofi (SNYNF)
Deutsche Bank analyst Emmanuel Papadakis maintained a Sell rating on Sanofi yesterday and set a price target of EUR70.00. The company’s shares closed last Tuesday at $97.56.
According to TipRanks.com, Papadakis is a 2-star analyst with an average return of 0.9% and a 54.0% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as Sanofi-Aventis Sa, Roche Holding AG, and GlaxoSmithKline.
Currently, the analyst consensus on Sanofi is a Moderate Buy with an average price target of $115.56.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SNYNF:
